弘晖资本 (Honghui Capital)
Overview
Honghui Capital is a venture capital firm that specializes in the healthcare industry, including the biopharmaceutical industry chain, medical devices, and health consumption sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Dreo | Dec 2025 | Series C | Co-investor |
| 求臻医学 | Apr 2020 | Series B Extension | Co-investor |
| BIBO (Shanghai) Automotive Electronics Co., Ltd. | - | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is 弘晖资本 (Honghui Capital) based?
弘晖资本 (Honghui Capital) is headquartered in Shanghai, China.
When was 弘晖资本 (Honghui Capital) founded?
弘晖资本 (Honghui Capital) was founded in 2014.
How many portfolio companies does 弘晖资本 (Honghui Capital) have?
弘晖资本 (Honghui Capital) has 3 portfolio companies in Caplight's dataset.
What are some companies in 弘晖资本 (Honghui Capital)'s portfolio?
Recent investments visible on Caplight include Dreo, 求臻医学, 求臻医学, BIBO (Shanghai) Automotive Electronics Co., Ltd..
What was 弘晖资本 (Honghui Capital)'s most recent investment?
弘晖资本 (Honghui Capital)'s most recent investment on Caplight was in Dreo in 2025.
What sectors does 弘晖资本 (Honghui Capital) focus on?
弘晖资本 (Honghui Capital) focuses on Consumer & Commerce, Healthcare & Life Sciences, Frontier & Industrial Tech, Mobility, Transportation & Logistics, AI, Data & Cloud Infrastructure.
What company stages does 弘晖资本 (Honghui Capital) focus on?
弘晖资本 (Honghui Capital) typically invests at the Early stage.
What is 弘晖资本 (Honghui Capital)'s AUM?
弘晖资本 (Honghui Capital)'s assets under management are estimated between $3.8B and $3.8B.